维普中文期刊产品整合服务
88篇 您的检索式:作者名="Adrian N"
    题名 作者 年代 出处 被引量
1Advances in endoscopic ultrasound imaging of colorectaldiseases显示文摘The development of endoscopic ultrasound(EUS) has had a significant impact for patients with digestive diseases, enabling enhanced diagnostic and therapeutic procedures, with most of the available evidence focusing on upper gastrointestinal(GI) and pancreaticobiliary diseases. For the lower GI tract the main application of EUS has been in staging rectal cancer, as a complementary technique to other cross-sectional imaging methods. EUS can provide highly accurate indepth assessments of tumour infiltration, performing best in the diagnosis of early rectal tumours. In the light of recent developments other EUS applications for colorectal diseases have been also envisaged and are currently under investigation, including beyond-rectum tumour staging by means of the newly developed forward-viewing radial array echoendoscope. Due to its high resolution, EUS might be also regarded as an ideal method for the evaluation of subepithelial lesions. Their differential diagnosis is possible by imaging the originating wall layer and the associated echostructure, and cytological and histological confirmation can be obtained through EUS-guided fine needle aspiration or trucut biopsy. However, reports on the use of EUS in colorectal subepithelial lesions are currently limited. EUS allows detailed examination of perirectal and perianal complications in Crohn's disease and, as a safe and less expensive investigation, can be used to monitor therapeutic response of fistulae, which seems to improve outcomes and reduce the need for additional surgery. Furthermore, EUS image enhancement techniques, such as the use of contrast agents or elastography, have recently been evaluated for colorectal indications as well. Possible applications of contrast enhancement include the assessment of tumour angiogenesis in colorectal cancer, the monitoring of disease activity in inflammatory bowel disease based on quantification of bowel wall vascularization, and differentiating between benign and malignant subepithelial tumours. Recent reports suggest that EUS elastography enables highly accurate discrimination of colorectal adenocarcinomas from adenomas, while inflammatory bowel disease phenotypes can be distinguished based on the strain ratio calculation. Among EUS-guided therapies, the drainage of abdominal and pelvic collections has been regarded as a safe and effective procedure to be used as an alternative for the transcutaneous route, while the placing of fiducial markers under EUS guidance for targeted radiotherapy in rectal cancer or the use of contrast microbubbles as drug-delivery vehicles represent experimental therapeutic applications that could greatly impact the forthcoming management of patients with colorectal diseases, pending on further investigations.Elena Tatiana Cârțână Dan IonuțGheonea Adrian Săftoiu 2016World Journal of Gastroenterology2016,22,5:14
2Confocal laser endomicroscopy and immunoendoscopy for real-time assessment of vascularization in gastrointestinal malignancies显示文摘Gastrointestinal cancers represent a major cause of morbidity and mortality,with incomplete response to chemotherapy in the advanced stages and poor prognosis.Angiogenesis plays a crucial part in tumor growth and metastasis,with most gastrointestinal cancers depending strictly on the development of a new and devoted capillary network.Confocal laser endomicroscopy is a new technology which allows in vivo microscopic analysis of the gastrointestinal mucosa and its microvascularization during ongoing endoscopy by using topically or systemically administered contrast agents.Targeting markers of angiogenesis in association with confocal laser endomicroscopic examination(immunoendoscopy),as a future challenge,will add functional analysis to the morphological aspect of the neoplastic process.This review describes previous experience in endomicroscopic examination of the upper and lower digestive tract with emphasis on vascularization,resulting in a broad spectrum of potential clinical applications,and also preclinical research that could be translated to human studies.Dan Ionut Gheonea Tatiana Crtnǎ Tudorel Ciurea Carmen Popescu Anca Bǎdǎrǎu Adrian Sǎftoiu 2011World Journal of Gastroenterology2011,17,1:6
3Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus显示文摘AIM:To assess tumour regression grade(TRG)and lymph node downstaging to help define patients who benefit from neoadjuvant chemotherapy.METHODS:Two hundred and eighteen consecutive patients with adenocarcinoma of the esophagus or gastro-esophageal junction treated with surgery alone or neoadjuvant chemotherapy and surgery between 2005and 2011 at a single institution were reviewed.Triplet neoadjuvant chemotherapy consisting of platinum,fluoropyrimidine and anthracycline was considered for operable patients(World Health Organization performance status≤2)with clinical stage T2-4 N0-1.Response to neoadjuvant chemotherapy(NAC)was assessed using TRG,as described by Mandard et al.In addition lymph node downstaging was also assessed.Lymph node downstaging was defined by cN1 at diagnosis:assessed radiologically(computed tomography,positron emission tomography,endoscopic ultrasonography),then pathologically recorded as N0 after surgery;ypN0 if NAC given prior to surgery,or pN0if surgery alone.Patients were followed up for 5 years post surgery.Recurrence was defined radiologically,with or without pathological confirmation.An association was examined between t TRG and lymph node downstaging with disease free survival(DFS)and a comprehensive range of clinicopathological characteristics.RESULTS:Two hundred and eighteen patients underwent esophageal resection during the study interval with a mean follow up of 3 years(median follow up:2.552,95%CI:2.022-3.081).There was a 1.8%(n=4)inpatient mortality rate.One hundred and thirty-six(62.4%)patients received NAC,with 74.3%(n=101)of patients demonstrating some signs of pathological tumour regression(TRG 1-4)and 5.9%(n=8)having a complete pathological response.Forty four point one percent(n=60)had downstaging of their nodal disease(cN1 to ypN0),compared to only 15.9%(n=13)that underwent surgery alone(pre-operatively overstaged:cN1 to pN0),(P<0.0001).Response to NAC was associated with significantly increased DFS(mean DFS;TRG 1-2:5.1years,95%CI:4.6-5.6 vs TRG 3-5:2.8 years,95%CI:2.2-3.3,P<0.0001).Nodal down-staging conferred a significant DFS advantage for those patients with a poor primary tumour response to NAC(median DFS;TRG 3-5 and nodal down-staging:5.533 years,95%CI:3.558-7.531 vs TRG 3-5 and no nodal down-staging:1.114 years,95%CI:0.961-1.267,P<0.0001).CONCLUSION:Response to NAC in the primary tumour and in the lymph nodes are both independently associated with improved DFS.Fergus Noble Luke Nolan Adrian C Bateman James P Byrne Jamie J Kelly Ian S Bailey Donna M Sharland Charlotte N Rees Timothy J Iveson Tim J Underwood Andrew R Bateman 2013World Journal of Gastroenterology2013,19,48:4
4One-day versus two-day cleansing for colon capsule endoscopy: a prospective randomized pilot study显示文摘Laura Ramos Onofre Alarcón Zaida Adrian Antonio Z. Gimeno-García David Nicolás-Pérez Alejandro Jiménez-Sosa Enrique Quintero 2013Gastroenterologia y Hepatologia2013,,:2
5Anaerobic treatment of pinkwater in a fluidized bed reactor containing GAC 显示文摘Maloney S W Adrian N R Hickey R F 2002J Hazard Mater2002,92,1:1
6Anaerobic treatment of pinkwater in a fluidized bed reactor containing GAC显示文摘MALONEY S W ADRIAN N R HICKEY R F 2002Journal of Hazardous Materials2002,92,:1
7Theoretical com- parison of low GWP alternatives for different refrigeration configurations taking R404A as baseline显示文摘Adrian M B Joaquin N E Angel B 2014International Journal of Refrigeration2014,44,1:1
8Anaerobic treatment of pinkwater in a fluidized bed reactor containing GAC 显示文摘Stephon W M Adrian N R Hickey R F 2002Journal of Hazardous Materials2002,92,1:1
9Percutaneous biliary metal wall stent-ing in malignant obstructive jaundice显示文摘Adrian A Indara Dileep N 2003Euro J Gastroenterol&Hepatol2003,15,8:1
10Drop-in energy performance evaluation of R1234yf and R1234ze(E) in a vapor compression system as R134a replacements 显示文摘Adrian M B Joaquin N E Angel B 2014Ap- plied Thermal Engineering2014,71,1:1
11Partitioning solute transport between infiltration and overland flow under rainfall显示文摘Havis R N Smith R E Adrian D D 1992Water Resources Research1992,28,10:1
12Measurement and prediction of spin losses in the EHL point contacts of the full toroidal variator显示文摘JONATHON N ADRIAN L 2004Transient Processes in Tribology2004,43,:1
13Decentralized generation of electricity with solid oxide fuel cells from centrally converted biomass显示文摘Toonssen R Woudstra N Adrian H M 2010International Journal of Hydrogen Energy2010,35,:1
14Anaerobic bioaansformation of explosives in aquifer slurries amended with ethanol and propylene glycol显示文摘ADRIAN N R ARNETT C M 2007Chemosphere2007,66,10:1
15Partitioning solute transport between infiltration and overland flow under rainfall 显示文摘Havis R N Smith R E Adrian D D 1992Water Resour Res1992,28,10:1
16Percutaneous biliary metal wall stenting in malignant obstructive jaundice显示文摘Adrian A Indar Dileep N Lobo Andrew D Gilliam Roger Gregson Ian Davidson Simon Whittaker John Doran Brian J Rowlands Ian J Beckingham 2003European Journal of Gastroenterology & Hepatology2003,,:1
17Two applications of solid phantoms in performance assessment of optical coherence tomography systems 显示文摘Avanaki Mohammad R N Podoleanu Adrian Gh Price Mark C 2013Applied Optics(S1559-128X)2013,52,29:1
18Influence of citric acid as chemical modifier for lead determination in dietary calcium supplement samples by graphite furnace atomic absorption spectrometry显示文摘Julio Cezar Paz de M Adriane M N Ayrton F M 2005Spectrochimica Acta Part B2005,60,5:1
19Oil transport in surfzone显示文摘CHENG N S LAW W K ADRIAN A N 2000Journal of hydraulic enginerring2000,,:1
20Terahertz imaging system based on a backwardwave oscillator显示文摘Adrian Dobroiu Masatsugu Yamashita Yuichi N Ohshi-ma 2004Applied Optics2004,43,30:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费